C - Index
In this guide
In this guideOn this page
Skip the menu of subheadings on this page.|
Subject : Cadmium, |
Year |
Page |
|
in the 2006 Total Diet Study in the infant diet |
2009 |
12 |
|
establishing a revised Tolerable Weekly Intake (TWI) |
2009 |
12 |
|
Comparing exposure to the TWI established in 2009 |
2018 |
9 |
|
ongoing work on the COT contribution to the SACN risk assessment on nutrition and, cadmium |
2021 |
31 |
|
Subject: Caffeine |
Year |
Page |
|
Caffeine and alcohol: combined effects on health and behaviour |
2012 |
7 |
|
EFSA consultation on a draft scientific opinion on the safety of caffeine |
2015 |
7 |
|
Reproductive effects of |
2001 |
22 |
|
Reproductive effects of |
2007 |
24 |
|
Reproductive effects of |
2008 |
14, 49 |
|
Subject: Calcium-parathyroid hormone axis |
Year |
Page |
|
Phosphate and the, |
2004 |
11, 54 |
|
Subject: Cancer |
Year |
Page |
|
Oesophageal cancer |
2004 |
178 |
|
The role of miRNA related effects and chemicals on cancer |
2011 |
56 |
|
Subject: Cancer aetiology |
Year |
Page |
|
and causal inference. |
2017 |
53 |
|
Subject: Cancer incidence near municipal solid wasteincinerators |
Year |
Page |
|
in Great Britain |
2000 |
104 |
|
Update review of epidemiological studies on |
2008 |
284 |
|
Review of |
2009 |
240 |
|
Subject: Cancer risk |
Year |
Page |
|
DNA adducts as a biomarker for |
2008 |
277 |
|
Joint COC/COM symposium on genetic susceptibility to cancer |
1998 |
35 |
|
Epidemiological data linking cancer and alcohol |
1995 |
58 |
|
Modification of, COC discussion of |
2021 |
76 |
|
Subject: Cannabidiol (CBD) |
Year |
Page |
|
Cosmetic products, potential risks from use of topically applied CBD-containing |
2020 |
28 |
|
COT review of, |
2019 |
16, 36 |
|
Genotoxicity of, COM evaluation |
2020 |
50 |
|
Inhalation, potential adverse effects associated with exposure to CBD) by |
2020 |
28 |
|
Position paper on CBD in food products |
2020 |
11 |
|
Updated position paper on |
2021 |
24 |
|
Subject: Canned foods |
Year |
Page |
|
Bisphenol A in |
2001 |
8 |
|
Subject: Captan (fungicide) |
Year |
Page |
|
COM and COC Evaluation of |
1993 |
35, 50 |
|
Subject: Caramel (Type 1) |
Year |
Page |
|
Evaluation of |
1991 |
30 |
|
Subject: Carbaryl |
Year |
Page |
|
COM and COC Evaluation of |
1995 |
30, 64 |
|
Subject: Carbon nanotubes |
Year |
Page |
|
Carcinogenicity of |
2010 |
60 |
|
Carcinogenicity of |
2011 |
58 |
|
Subject: Carcinogenesis |
Year |
Page |
|
age-related differences in susceptibility to |
2006 |
281 |
|
mode of action / human relevance framework |
2005 |
134 |
|
mode of action / human Relevance Framework |
2008 |
279 |
|
“Tissue Organisation Field Theory” of |
2006 |
286 |
|
Carcinogenic air pollutants, Quantification of risk |
2002 |
128 |
|
Carcinogenicity guidelines |
1991 |
44 |
|
Subject: Carcinogens |
Year |
Page |
|
COC guidance on a strategy for the risk assessment of |
2004 |
188 |
|
Assessing the risks of acute or short-term exposure to |
2007 |
179 |
|
Early life exposure- assessing susceptibility from EPA risk assessment guideline: supplemental data for |
2003 |
195 |
|
Guidance Statements on the risk assessment of |
2010 |
63 |
|
Occupational, HSE priority programme |
2004 |
177 |
|
Insulin-like growth factor-1 (IGF-1) in the diet, The potential carcinogenic risk of |
2009 |
78 |
|
Interaction between genotype and chemicals in the environment on the induction of cancer in risk assessment |
2011 |
53 |
|
Risk assessment of carcinogens, Revised guidance |
2003 |
197 |
|
COC guidance on a strategy for the risk assessment of carcinogens |
2004 |
188 |
|
Single or short term exposure to carcinogens |
2005 |
140 |
|
Use of target organ mutagenicity data in carcinogen risk assessment |
2005 |
124 |
|
Organ mutagencity data in carcinogen risk assessment |
2005 |
124 |
|
Subject: Carcinogenicity |
Year |
Page |
|
Chemical carcinogenicity revisited |
2019 |
50 |
|
Testing for carcinogenicity of pharmaceuticals |
1997 |
112 |
|
Joint COM/COC on the significance of low level exposures to DNA adduct inducing chemicals |
1996 |
48 |
|
‘Risk assessment methodologies and approaches for mutagenic and carcinogenic substances’, Preliminary Report by the EU Scientific Committees on Consumer Products, on Health and Environmental Risks, and on Emerging and Newly-Identified Risks on |
2008 |
280 |
|
Subject: Carcinogenicity studies |
Year |
Page |
|
|
in rats, Minimum duration of |
2001 |
121 |
|
|
in rats, Minimum duration of |
2002 |
130 |
|
|
OECD Guidance document for the performance of chronic toxicity and |
2009 |
225 |
|
|
Revision of OECD Test Guidelines for |
2008 |
282 |
|
|
tobacco products, testing of |
2009 |
219 |
|
|
Longevity of carcinogenicity studies: consideration of a database prepared by the Pesticides Safety Directorate |
2000 |
109 |
|
|
Nephropathy observed in a 2-year carcinogenicity study |
2008 |
12 |
|
|
T25 to estimate carcinogenic potency |
1995 |
72 |
|
|
Validation of short-term carcinogenicity tests using transgenic animals, Presentation on |
1999 |
73 |
|
Subject: Carrageenan |
Year |
Page |
|
Allergic food intolerance, COT evaluation of |
1997 |
11 |
|
Immune system, possible effects due to uptake by the gut-associated lymphoid tissues. |
1993 |
12 |
|
Infant formulae, COT evaluation of use in |
1991 |
14 |
|
Subject: Cell lines expressing human xenobiotic metabolising enzyme in mutagenicity testing |
Year |
Page |
|
COM review of |
1995 |
38 |
|
Subject: Cell transformation assays |
Year |
Page |
|
COM review of |
1994 |
26 |
|
COM review of |
2012 |
44 |
|
For the prediction of carcinogens |
2012 |
37 |
|
Subject: Chemical risk assessment |
Year |
Page |
|
Evolving approaches to, |
2007 |
23, 38 |
|
Interaction between genotype and chemicals in the environment on the induction of cancer in risk assessment |
2011 |
53 |
|
Subject: Childhood cancer |
Year |
Page |
|
Age as an independent risk factor for chemically induced acute myelogenous leukaemia in children |
2008 |
276 |
|
Childhood leukaemia and residence near sources of traffic exhaust and petrol fumes: review of the possible associations between |
2005 |
143 |
|
Hazard proximities in Great Britain (from 1953 to 1980) |
1997 |
110 |
|
Ongoing COC review of |
2004 |
191 |
|
Ongoing COC review of |
2005 |
134 |
|
Paternal smoking and |
1997 |
68 |
|
Subject: Children |
Year |
Page |
|
Research project (T07040) investigating the effect of mixtures on certain food colours and a preservative on behaviour in |
2007 |
8, 49 |
|
Children’s Environment and Health Strategy for the UK |
2008 |
9 |
|
Subject: Chlordecone |
Year |
Page |
|
Endosulfan, pentachlorobenzene and in the infant diet |
2013 |
18 |
|
Subject: Chlorinated and brominated contaminants |
Year |
Page |
|
in shellfish, farmed and wild fish |
2006 |
10, 67 |
|
Subject: Chlorinated drinking water |
Year |
Page |
|
Mutagenic activity of |
1991 |
32 |
|
Epidemiology and cancer |
1992 |
55 |
and cancer |
Year |
Page |
|
Chlorinated drinking water |
2007 |
185 |
|
Chlorinated drinking water |
2008 |
278, 285 |
and reproductive outcomes |
Year |
Page |
|
Chlorinated Drinking Water and |
1998 |
8 |
|
Chlorinated drinking water and |
2001 |
18 |
|
Chlorinated drinking water |
2004 |
8, 46 |
|
Chlorinated paraffins in food |
2009 |
13, 111 |
|
Chlorination disinfection by-products and risk of congenital anomalies in England and Wales – new SAHSU study |
2008 |
9 |
|
Subject: Chlorine and chlorine dioxide as flour treatment agents |
Year |
Page |
|
COM review of |
1993 |
33 |
|
COT and COM review of |
1996 |
7, 36 |
|
Subject: Chlorobenzenes |
Year |
Page |
|
COT review of |
1997 |
12 |
2-Chlorobenzylidene malonitrile (CS) |
Year |
Page |
|
COT review of |
1998 |
32 |
|
new formulation of, and PAVA (Nonivamide) sprays: combined use and CS Spray |
|
|
|
new formulation of PAVA (Nonivamide) and CS Spray respectively |
2017 |
28 |
|
Ongoing work, co-exposure |
2005 |
17 |
|
co-exposure |
2006 |
7, 21 |
|
Review of CS Spray as a chemical incapacitant in relation to potential public health concerns |
1999 |
7, 51 |
|
Combined use of CS (2-chloro-benzylidene malonitrile) and PAVA (nonivamide) (captor 2) irritant sprays |
2013 |
14 |
|
Subject: Chlorodibromomethane and chloroform |
Year |
Page |
|
See trihalomethanes in drinking water |
1994 |
22, 23, 32 |
|
Subject: Chlorophenols |
Year |
Page |
|
COM review of genotoxicity |
2011 |
45 |
|
genotoxicity of |
2012 |
37 |
|
Subject: Cholangiocarcinoma |
Year |
Page |
|
Evidence for an increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1996 |
2000 |
107 |
|
in the rat |
2005 |
155 |
|
Subject: Chromium picolinate |
Year |
Page |
|
COM ongoing review of |
2003 |
141 |
|
COM review of the available information on the mutagenicity of trivalent chromium and specifically on chromium picolinate |
2004 |
135, 148 |
|
Subject: Chromium VI |
Year |
Page |
|
COM review of |
2015 |
36 |
|
Subject: Chrysotile-substitutes, |
Year |
Page |
|
Carcinogenic risks |
1998 |
50 |
|
Subject: Chymosin (enzyme) |
Year |
Page |
|
from genetically modified Escherichia coli K12 in cheese manufacture |
1991 |
16, 28 |
|
Enzyme submission to COT |
2000 |
16 |
|
Enzyme submission; chymosin preparation derived from GM aspergillus niger var. awamori |
2002 |
10 |
|
Subject: Climate change |
Year |
Page |
|
COC evaluation of |
2011 |
52 |
|
Subject: COC guidance |
Year |
Page |
|
Review of |
2001 |
142 |
|
Revision of |
2002 |
134 |
|
COC template |
2002 |
129 |
|
COM template |
2002 |
87 |
|
on a strategy for the risk assessment of carcinogens |
2004 |
188 |
|
Subject: COM guidance |
Year |
Page |
|
On ICH guidelines: Genotoxicity: A standard battery for genotoxicity testing of pharmaceuticals (S2B) and consideration of the mouse lymphoma assay |
1997 |
75 |
|
Joint COM/COC on the significance of low level exposures to DNA adduct inducing chemicals |
1996 |
48 |
|
Joint symposium with COM on use of target organ mutagenicity in carcinogen risk assessment |
2004 |
192 |
|
Joint meeting of COT/COM on use of target organ mutagenicity assays in carcinogen risk assessment |
2005 |
92, 124 |
|
Subject: CONCAWE |
Year |
Page |
|
Assessment of exposure to petrol vapour |
2005 |
145 |
|
Assessment of exposure to benzene vapour |
2005 |
146 |
|
Subject: Comet Assay |
Year |
Page |
|
in mutagenicity testing strategies |
1998 |
35 |
|
published literature on the use of this assay to detect chemical mutagens |
1995 |
39 |
|
Statement on joint COC and COM meeting 9 June 2005 |
2005 |
125 |
|
Statement on a comparison of the relative performance of the in vivo rat liver UDS assay and the in vivo Comet assay |
2006 |
249 |
|
Subject: Comfrey |
Year |
Page |
|
Report, pyrrolizidine alkaloid (PA), in vivo data |
1992 |
19 |
|
results of a survey of comfrey |
1994 |
7 |
|
Subject: Committee procedures |
Year |
Page |
|
Code of Conduct for Observers |
2007 |
18 |
|
Code of practice, revision of COT |
2020 |
21 |
|
Code of Practice for Scientific Advisory Committees CoPSAC) second round of consultation |
2001 |
106 |
|
Code of Practice for Scientific Advisory Committees, the updating of. |
2007 |
18 |
|
Consultation document for updating the Code of Practice for Scientific Advisory Committees |
2010 |
23 |
|
EFSA consultation on draft guidance on biological relevance |
2017 |
17 |
|
EFSA consultation on draft guidance on the risk assessment of substances present in food intended for infants below 16 weeks of age |
2017 |
19 |
|
EFSA consultation on draft guidance on weight of evidence |
2017 |
18 |
|
EFSA opinion on statistical significance and biological relevance |
2011 |
22 |
|
Draft EFSA protocol for a systematic review on health outcomes related to the age of introduction of complementary food for the scientific assessment of the appropriate age of introduction of complementary feeding into an infant’s diet |
2017 |
20 |
|
EFSA consultation on draft EFSA/ECHA guidance for the identification of endocrine disruptors in the context of Regulations (EU) No 528/2012 and (EC) No 1107/2009 |
2018 |
17 |
|
EFSA consultation on draft guidance on risk assessment of the application of nanoscience and nanotechnologies in the food and feed chain: Part 1, human and animal health |
2018 |
18 |
|
EFSA consultation on draft guidance on threshold of toxicological concern approach |
2018 |
20 |
|
EFSA public consultation on draft Scientific Opinion on evaluation of the health risks related to the presence of cyanogenic glycosides in foods other than raw apricot kernels |
2018 |
20 |
|
Public consultation on the EFSA Opinion on “Risk for animal and human health related to the presence of dioxins and dioxin-like PCBs in feed and food.” |
2018 |
20 |
|
EFSA public consultation on the MIXTOX guidance |
2018 |
21 |
|
EFSA safety assessment of certain flavouring substances, COM consideration |
2018 |
42 |
|
EFSA consultation on genotoxicity of mixtures |
2018 |
42 |
|
EFSA consultation on phthalates |
2019 |
14 |
|
EFSA consultation on the EFSA opinion on risk to public health related to the presence of ochratoxin in food. |
2020 |
22 |
|
EFSA Public consultation on the EFSA draft Opinion “Risk to human health related to the presence of perfluoroalkyl substances in food |
2020 |
23 |
|
EFSA consultation on the EFSA opinion on risks for animals and human health related to the presence of glycoalkaloids in feed and food, in particular in potatoes and potato-derived products |
2020 |
24 |
|
EFSA Public consultation on the EFSA draft “Update of the risk assessment of nickel in food and drinking water” |
2020 |
25 |
|
EFSA consultation on the EFSA opinion on the update of the risk assessment of hexabromocyclododecanes (HBCDDs) in food |
2020 |
26 |
|
EFSA recommendations on Default values to be used in risk assessment in the absence of actual measured data |
2012 |
7 |
|
Review of the 2018 EFSA opinion on dioxins |
2021 |
18 |
|
Review of the 2021EFSA opinion on titanium dioxide |
2021 |
23 |
|
Draft EFSA Scientific Committee Opinion on scientific criteria for grouping chemicals into assessment groups for human risk assessment of combined exposure to multiple chemicals |
2021 |
26 |
|
Draft EFSA Scientific Committee Opinion on biological plausibility of non-monotonic dose responses and their impact on the risk assessment |
2021 |
27 |
|
EFSA draft opinion on “Identification and prioritisation for risk assessments of phthalates, structurally similar substances potentially used as plasticisers in materials and articles intended to come into contact with food” and “draft protocol for the exposure assessment as part of the safety assessment of phthalates, structurally similar substances potentially used as plasticisers in materials and articles intended to come into contact with food” |
2021 |
28 |
|
Food Standards Agency review of scientific committees |
2001 |
24 |
|
Good Practice Agreement for Scientific Advisory Committees |
2006 |
16 |
|
Public Consultation on Code of Practice for Scientific Advisory Committees and Councils |
,2021 |
29 |
|
Horizon Scanning: Multiple emerging or developing topics of importance within the COT / COM / COC remit. |
Every year |
Consult individual report |
|
In the light of the Phillips enquiry (COC) |
2001 |
9, 106 |
|
Open Meetings – review of procedure |
2006 |
17 |
|
Peer review by EU-ANSA agencies |
2017 |
20 |
|
Performance evaluation for Committee members |
2006 |
17 |
|
Procedure for holding COT meetings in open session |
2003 |
18 |
|
Quinquennial Review of the COT |
2011 |
23 |
|
Reviews of risk procedures used by Government advisory Committees dealing with food (COM) |
2000 |
22, 110 |
|
Second round of consultation |
2003 |
12, 106 |
|
Uncertainty framework from a social science perspective |
2011 |
25 |
|
WHO public consultation on the JECFA/JMPR update of Chapter 5 (EHC 240) |
2020 |
26, 51 |
|
Subject: Committee workshops |
Year |
Page |
|
Bystander Risk Assessment Working Group (BRAWG) |
2011 |
26 |
|
Diet and drug interaction |
2005 |
7 |
|
ECETOC workshop on use of T25 in chemical carcinogen evaluation |
2001 |
141 |
|
Epigenetics in carcinogenesis |
2016 |
42 |
|
Epigenetics, transgenerational |
2008 |
19, 36 |
|
Exploring Dose- response |
2020 |
21 |
|
Genotoxicity data, interpretation of |
2020 |
48 |
|
ILSI/HESI workshop on less-than-lifetime exposure to carcinogens |
2012 |
44 |
|
International workshop on the categorisation of mutagens |
2001 |
108 |
|
PBPK for regulators |
2020 |
22 |
|
Social Science insights for risk assessment |
2006 |
17 |
|
Subject: Contaminants in the diet of infants and young children |
Year |
Page |
|
Overarching statement. |
2019 |
8 |
|
possible health risks from the exposure of infants to HBCDDs in breast milk, dust and food |
2014 |
12 |
|
contaminants in- overarching statement. |
2019 |
8 |
|
Subject: Contaminants in soil |
Year |
Page |
|
assessing the possible risks to human health associated with exposure to |
2001 |
10 |
|
Updated framework guidance, establishing a TDI |
2008 |
9 |
|
new screening levels |
2013 |
15, 54 |
|
Subject: Copper |
Year |
Page |
|
in the infant diet |
2018 |
10 |
|
Subject: Coumarin |
Year |
Page |
|
And liver cancer, COT review of |
1998 |
29, 41 |
|
Subject: CRISPR gene editing technology- |
Year |
Page |
|
potential for genotoxicity |
2018 |
41 |
|
Subject: CS Sabre 540010-01, |
Year |
Page |
|
new formulation |
2018 |
16 |
|
Subject: Cyanogenic glycosides |
Year |
Page |
|
in apricot kernels |
2006 |
7, 29 |
|
EFSA public consultation on draft Scientific Opinion on evaluation of the health risks related to the presence of cyanogenic glycosides in foods other than raw apricot kernels |
2018 |
20 |
|
Subject: Cyclamate |
Year |
Page |
|
COT review of |
1995 |
6 |
|
Subject: Cycloastragenol |
Year |
Page |
|
COC evaluation of |
2015 |
42 |